Literature DB >> 3356080

Kinetics of prednisolone and endogenous cortisol suppression in the elderly.

A E Stuck1, B M Frey, F J Frey.   

Abstract

The kinetics of prednisolone after intravenous prednisolone and oral prednisone were investigated in 19 young (23 to 34 years) and 12 elderly (65 to 89 years) subjects. The systemic availability of unbound prednisolone after oral prednisone and the apparent interconversion of prednisolone into prednisone and vice versa (reflecting the activity of the 11 beta-hydroxydehydrogenase) were independent of age. The total exposure of the elderly subjects to prednisolone was increased because the nonrenal (5.7 +/- 1.0 vs. 7.7 +/- 1.6 ml/min/kg, mean +/- SD; P less than 0.001) and renal (0.9 +/- 0.3 vs. 2.9 +/- 0.7 ml/min/kg; P less than 0.001) clearances of unbound prednisolone were lower in the elderly. The fractional clearance of 6 beta-hydroxyprednisolone (reflecting the activity of the 6 beta-hydroxylase) decreased linearly with the metabolic clearance of prednisolone. Despite increased prednisolone exposure, elderly subjects had higher endogenous cortisol concentrations. It was concluded that elderly subjects exhibit higher concentrations of both total and unbound prednisolone. Despite this greater exposure of target tissues, there appears to be less suppression of endogenous cortisol concentrations in plasma compared with younger subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356080     DOI: 10.1038/clpt.1988.43

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients.

Authors:  Katherine A Barraclough; Nicole M Isbel; Brett C McWhinney; Jacobus P J Ungerer; Gregory Medley; David W Johnson; Carmel M Hawley; Diana R Leary; Scott B Campbell; Christine E Staatz
Journal:  Eur J Clin Pharmacol       Date:  2011-06-09       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

Review 4.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 5.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 6.  A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.

Authors:  Felix Krenzien; Abdallah ElKhal; Markus Quante; Hector Rodriguez Cetina Biefer; Uehara Hirofumi; Steven Gabardi; Stefan G Tullius
Journal:  Transplantation       Date:  2015-11       Impact factor: 4.939

Review 7.  Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.

Authors:  Dirk R J Kuypers
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Endogenous urinary glucocorticoid metabolites and mortality in prednisolone-treated renal transplant recipients.

Authors:  Annet Vulto; Isidor Minović; Laura V de Vries; Arwin C Timmermans; Martijn van Faassen; Antonio W Gomes Neto; Daan J Touw; Margriet F C de Jong; André P van Beek; Robin P F Dullaart; Gerjan Navis; Ido P Kema; Stephan J L Bakker
Journal:  Clin Transplant       Date:  2020-03-03       Impact factor: 2.863

9.  Immunosuppression Considerations for Older Kidney Transplant Recipients.

Authors:  Wisit Cheungpasitporn; Krista L Lentine; Jane C Tan; Matthew Kaufmann; Yasar Caliskan; Suphamai Bunnapradist; Ngan N Lam; Mark Schnitzler; David A Axelrod
Journal:  Curr Transplant Rep       Date:  2021-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.